American depositary receipts of European stocks were trading 0.35% higher at 1,062.35 on the BNY Mellon Europe Select ADR Index on Monday.
In continental Europe, the gainers were led by internet browser company Opera (OPRA) and biotech firm Zealand Pharma (ZEAL), which rose 4.2% and 3.8% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and pharmaceutical company Oasmia Pharmaceutical (OASM), which were up 3.5% and 3.1%.
The decliners in continental Europe were led by network infrastructure operator Nokia (NOK), and hotel booking site Trivago (TRVG), which fell 4.4% and 3.3% respectively. They were followed by telecommunications company Ericsson (ERIC) and semiconductor company STMicroelectronics (STM), which dropped 1.3% each.
In the UK and Ireland, the gainers were led by public relations group WPP (WPP) and insurance firm Prudential (PUK), which were up 1.5% and 1.4% respectively. They were followed by Barclays Bank (BCS) and telecommunications operator BT Group (BT), which rose 1.2% and 0.9%.
The decliners in the UK and Ireland were led by pharmaceutical company Avadel (AVDL) and specialty pharmaceutical company Motif Bio (MTFB), which lost 4.7% and 1.9% respectively. They were followed by biopharmaceutical firm Amarin (AMRN) and mining company BHP Billiton (BBL), which were down 1.6% and 1.2%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.